Il-10 producing T and B cells in allergy

Akdis, 2014, Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs, J. Clin. Invest., 124, 4678, 10.1172/JCI78891 Akdis, 2016, Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases, J. Allergy Clin. Immunol., 138, 984, 10.1016/j.jaci.2016.06.033 Jutel, 2006, Mechanisms of allergen specific immunotherapy--T-cell tolerance and more, Allergy, 61, 796, 10.1111/j.1398-9995.2006.01175.x Ouyang, 2011, Regulation and functions of the IL-10 family of cytokines in inflammation and disease, Annu. Rev. Immunol., 29, 71, 10.1146/annurev-immunol-031210-101312 Kotenko, 1997, Identification and functional characterization of a second chain of the interleukin-10 receptor complex, EMBO J., 16, 5894, 10.1093/emboj/16.19.5894 Taylor, 2007, IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1, J. Allergy Clin. Immunol., 120, 76, 10.1016/j.jaci.2007.04.004 Walter, 2014, The molecular basis of IL-10 function: from receptor structure to the onset of signaling, Curr. Top. Microbiol. Immunol., 380, 191 Palomares, 2014, Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta, Genes Immun., 15, 511, 10.1038/gene.2014.45 Ouyang, 2019, IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation, Immunity, 50, 871, 10.1016/j.immuni.2019.03.020 Akdis, 2015, Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens, World Allergy Organ. J., 8, 17, 10.1186/s40413-015-0063-2 Breiteneder, 2019, Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care, Allergy, 10.1111/all.13851 Agache, 2019, Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases, J. Clin. Invest., 130, 1493, 10.1172/JCI124611 Collier, 2019, Naive regulatory T cells in infancy: associations with perinatal factors and development of food allergy, Allergy, 10.1111/all.13822 Akdis, 2012, Therapies for allergic inflammation: refining strategies to induce tolerance, Nat. Med., 18, 736, 10.1038/nm.2754 Sugita, 2018, Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients, J. Allergy Clin. Immunol., 141, 300, 10.1016/j.jaci.2017.02.038 Globinska, 2018, Mechanisms of allergen-specific immunotherapy: diverse mechanisms of immune tolerance to allergens, Ann. Allergy Asthma Immunol., 121, 306, 10.1016/j.anai.2018.06.026 van de Veen, 2017, Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy, Curr. Opin. Immunol., 48, 74, 10.1016/j.coi.2017.08.012 Fujita, 2012, Mechanisms of allergen-specific immunotherapy, Clin. Transl. Allergy, 2, 2, 10.1186/2045-7022-2-2 Jutel, 2011, Immunological mechanisms of allergen-specific immunotherapy, Allergy, 66, 725, 10.1111/j.1398-9995.2011.02589.x Mitthamsiri, 2018, Decreased CRTH2 expression and response to allergen Re-stimulation on innate lymphoid cells in patients with allergen-specific immunotherapy, Allergy Asthma Immunol. Res., 10, 662, 10.4168/aair.2018.10.6.662 Akdis, 2014, Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens, J. Allergy Clin. Immunol., 133, 621, 10.1016/j.jaci.2013.12.1088 Palomares, 2017, Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells, Immunol. Rev., 278, 219, 10.1111/imr.12555 Soyka, 2012, Regulatory cells in allergen-specific immunotherapy, Immunotherapy, 4, 389, 10.2217/imt.12.10 Gueguen, 2019, IL-10 mRNA levels in whole blood cells correlate with house dust mite allergen immunotherapy efficacy, Allergy, 10.1111/all.13751 Jutel, 2003, IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy, Eur. J. Immunol., 33, 1205, 10.1002/eji.200322919 Akdis, 2004, Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J. Exp. Med., 199, 1567, 10.1084/jem.20032058 Loebbermann, 2012, Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection, Mucosal Immunol., 5, 161, 10.1038/mi.2011.62 Velaga, 2015, Granzyme a is required for regulatory T-Cell mediated prevention of gastrointestinal graft-versus-Host disease, PLoS One, 10, 10.1371/journal.pone.0124927 Gruarin, 2019, Eomesodermin controls a unique differentiation program in human IL-10 and IFN-gamma coproducing regulatory T cells, Eur. J. Immunol., 49, 96, 10.1002/eji.201847722 Meiler, 2008, In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure, J. Exp. Med., 205, 2887, 10.1084/jem.20080193 Ferstl, 2017, Histamine receptor 2 modifies iNKT cell activity within the inflamed lung, Allergy, 72, 1925, 10.1111/all.13227 Akdis, 1998, Role of interleukin 10 in specific immunotherapy, J. Clin. Invest., 102, 98, 10.1172/JCI2250 Baecher-Allan, 2004, Human CD4+CD25+ regulatory t cells, Semin. Immunol., 16, 89, 10.1016/j.smim.2003.12.005 Ito, 2008, Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery, Immunity, 28, 870, 10.1016/j.immuni.2008.03.018 Joss, 2000, IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway, Eur. J. Immunol., 30, 1683, 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A Kearley, 2005, Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent, J. Exp. Med., 202, 1539, 10.1084/jem.20051166 Akdis, 2006, Immunological mechanisms of sublingual immunotherapy, Allergy, 61, 11, 10.1111/j.1398-9995.2006.01159.x Ciprandi, 2006, Sublingual immunotherapy and regulatory T cells, Allergy, 61, 511, 10.1111/j.1398-9995.2006.01046.x Shin, 2018, Allergen-specific immunotherapy induces regulatory T cells in an atopic dermatitis mouse model, Allergy, 73, 1801, 10.1111/all.13465 Berings, 2017, Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance, J. Allergy Clin. Immunol., 140, 1250, 10.1016/j.jaci.2017.08.025 Scadding, 2017, JAMA, 317, 615, 10.1001/jama.2016.21040 Russkamp, 2019, IL-4 receptor alpha blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma, Allergy, 10.1111/all.13759 Boonpiyathad, 2019, Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy, Allergy, 74, 976, 10.1111/all.13684 Soria, 2018, Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice, Allergy, 73, 875, 10.1111/all.13396 Noval Rivas, 2016, Regulatory T cells in allergic diseases, J. Allergy Clin. Immunol., 138, 639, 10.1016/j.jaci.2016.06.003 Burzyn, 2013, A special population of regulatory T cells potentiates muscle repair, Cell, 155, 1282, 10.1016/j.cell.2013.10.054 Hong, 2018, Chitotriosidase inhibits allergic asthmatic airways via regulation of TGF-beta expression and Foxp3(+) Treg cells, Allergy, 73, 1686, 10.1111/all.13426 Varona, 2019, Persistent regulatory T-cell response 2 years after 3 years of grass tablet SLIT: links to reduced eosinophil counts, sIgE levels, and clinical benefit, Allergy, 74, 349, 10.1111/all.13553 Schneider, 2007, CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells, J. Exp. Med., 204, 735, 10.1084/jem.20061405 Duggleby, 2007, CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells, Immunology, 121, 129, 10.1111/j.1365-2567.2006.02550.x Tosello, 2008, Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs, Clin. Immunol., 126, 291, 10.1016/j.clim.2007.11.008 Joller, 2014, Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses, Immunity, 40, 569, 10.1016/j.immuni.2014.02.012 Gianchecchi, 2018, Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and Cancer progression, Front. Immunol., 9, 2374, 10.3389/fimmu.2018.02374 Chougnet, 2016, Helios-controller of Treg stability and function, Transl. Cancer Res., 5, S338, 10.21037/tcr.2016.07.37 Sun, 2016, GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-beta releasing, Oncotarget, 7, 42826, 10.18632/oncotarget.8753 Nowak, 2018, CD137+CD154- expression As a regulatory t cell (Treg)-Specific activation signature for identification and sorting of stable human tregs from in vitro expansion cultures, Front. Immunol., 9, 199, 10.3389/fimmu.2018.00199 Yadav, 2012, Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo, J. Exp. Med., 209, 1713, 10.1084/jem.20120822 Boonpiyathad, 2019, Impact of high altitude therapy on Type-2 immune responses in asthma patients, Allergy, 10.1111/all.13967 van de Veen, 2017, The role of regulatory B cells in allergen immunotherapy, Curr. Opin. Allergy Clin. Immunol., 17, 447, 10.1097/ACI.0000000000000400 van de Veen, 2016, Role of regulatory B cells in immune tolerance to allergens and beyond, J. Allergy Clin. Immunol., 138, 654, 10.1016/j.jaci.2016.07.006 van de Veen, 2016, Role of IgG4 in IgE-mediated allergic responses, J. Allergy Clin. Immunol., 138, 1434, 10.1016/j.jaci.2016.07.022 Satitsuksanoa, 2018, Regulatory immune mechanisms in tolerance to food allergy, Front. Immunol., 9, 2939, 10.3389/fimmu.2018.02939 Braza, 2014, Regulatory functions of B cells in allergic diseases, Allergy, 69, 1454, 10.1111/all.12490 Bianchini, 2019, IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance, Allergy, 74, 483, 10.1111/all.13635 van de Veen, 2013, IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses, J. Allergy Clin. Immunol., 131, 1204, 10.1016/j.jaci.2013.01.014 Stanic, 2015, IL-10-overexpressing B cells regulate innate and adaptive immune responses, J. Allergy Clin. Immunol., 135, 771, 10.1016/j.jaci.2014.07.041 Mauri, 2017, Human regulatory B cells in health and disease: therapeutic potential, J. Clin. Invest., 127, 772, 10.1172/JCI85113 Komlosi, 2018, Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells, J. Allergy Clin. Immunol., 142, 178, 10.1016/j.jaci.2017.07.046 Kamekura, 2015, Alteration of circulating type 2 follicular helper T cells and regulatory B cells underlies the comorbid association of allergic rhinitis with bronchial asthma, Clin. Immunol., 158, 204, 10.1016/j.clim.2015.02.016 van der Vlugt, 2014, CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide, Clin. Exp. Allergy, 44, 517, 10.1111/cea.12238 Wirz, 2019, Comparison of regulatory B cells in asthma and allergic rhinitis, Allergy, 74, 815, 10.1111/all.13672 Lee, 2010, Allergen-specific B cell subset responses in cow’s milk allergy of late eczematous reactions in atopic dermatitis, Cell. Immunol., 262, 44, 10.1016/j.cellimm.2009.12.006 Braza, 2015, A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation, Allergy, 70, 1421, 10.1111/all.12697 Xue, 2017, Protease-activated receptor-2 suppresses interleukin (IL)-10 expression in B cells via upregulating Bcl2L12 in patients with allergic rhinitis, Allergy, 72, 1704, 10.1111/all.13186 Boonpiyathad, 2019, Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy, J. Allergy Clin. Immunol., 143, 1077, 10.1016/j.jaci.2018.10.061 Schulke, 2018, Induction of Interleukin-10 producing dendritic cells As a tool to suppress allergen-specific t helper 2 responses, Front. Immunol., 9, 455, 10.3389/fimmu.2018.00455 Han, 2006, Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice, J. Immunol., 176, 5232, 10.4049/jimmunol.176.9.5232 Pacciani, 2010, Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites, J. Allergy Clin. Immunol., 125, 727, 10.1016/j.jaci.2009.12.004 Oh, 2002, CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation, J. Allergy Clin. Immunol., 110, 460, 10.1067/mai.2002.127512 Gentile, 2004, Diminished dendritic cell interleukin 10 production in atopic children, Ann. Allergy Asthma Immunol., 92, 538, 10.1016/S1081-1206(10)61761-9 Wei, 2014, An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17 response in allergic rhinitis patients, Lab. Invest., 94, 528, 10.1038/labinvest.2014.8 Pilette, 2013, Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis, Allergy, 68, 312, 10.1111/all.12090 Gueguen, 2016, Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy, J. Allergy Clin. Immunol., 137, 545, 10.1016/j.jaci.2015.09.015 Draijer, 2018, Dual role of YM1+ M2 macrophages in allergic lung inflammation, Sci. Rep., 8, 5105, 10.1038/s41598-018-23269-7 Draijer, 2017, Human asthma is characterized by more IRF5+ M1 and CD206+ M2 macrophages and less IL-10+ M2-like macrophages around airways compared with healthy airways, J. Allergy Clin. Immunol., 140, 280, 10.1016/j.jaci.2016.11.020 Said, 2010, Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, Nat. Med., 16, 452, 10.1038/nm.2106 Takeda, 2018, Mesenchymal stem cells recruit CCR2(+) monocytes to suppress allergic airway inflammation, J. Immunol., 200, 1261, 10.4049/jimmunol.1700562 Prasse, 2007, IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients, J. Allergy Clin. Immunol., 119, 464, 10.1016/j.jaci.2006.09.030 Deniz, 2013, Natural killer cells in patients with allergic diseases, J. Allergy Clin. Immunol., 132, 527, 10.1016/j.jaci.2013.07.030 Deniz, 2008, Regulatory NK cells suppress antigen-specific T cell responses, J. Immunol., 180, 850, 10.4049/jimmunol.180.2.850 Morita, 2019, Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid, J. Allergy Clin. Immunol., 143, 2190, 10.1016/j.jaci.2018.12.1018 Rigas, 2017, Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction, J. Allergy Clin. Immunol., 139, 1468, 10.1016/j.jaci.2016.08.034 Wang, 2017, Regulatory innate lymphoid cells control innate intestinal inflammation, Cell, 171, 201, 10.1016/j.cell.2017.07.027 Seehus, 2017, Alternative activation generates IL-10 producing type 2 innate lymphoid cells, Nat. Commun., 8, 1900, 10.1038/s41467-017-02023-z Akdis, 1996, Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro, J. Clin. Invest., 98, 1676, 10.1172/JCI118963 Muller, 1998, Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom, J. Allergy Clin. Immunol., 101, 747, 10.1016/S0091-6749(98)70402-6 Santos, 2019, Expansion of FOXP3(+) regulatory CD4 T cells upon exposure to hymenoptera venom during the beekeeping season, Allergy, 74, 1182, 10.1111/all.13713 Sokolowska, 2010, Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites, J. Allergy Clin. Immunol., 125, 1393, 10.1016/j.jaci.2010.02.016 Sokolowska, 2007, 85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study, Clin. Exp. Immunol., 150, 124, 10.1111/j.1365-2249.2007.03459.x Pniewska, 2014, The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: pilot study, Biomed Res. Int., 2014, 10.1155/2014/670814 Boonpiyathad, 2017, High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers, Allergy, 72, 407, 10.1111/all.12966